World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
140
Citations
129579
World Ranking
1649
National Ranking
961

Luis A. Diaz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Luis A. Diaz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 703 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Luis A. Diaz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Luis A. Diaz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 140 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Luis A. Diaz is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on oncology and related subfields.

Their main subfields of study include:

  • Oncology
  • Pathology and Forensic Medicine
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Genetics

The core topics of their research address various aspects of cancer biology and treatment, including:

  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Autoimmune Bullous Skin Diseases
  • Cancer Immunotherapy and Biomarkers
  • Pancreatic and Hepatic Oncology Research
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema

Luis A. Diaz has contributed to a significant number of research papers. Some recent notable publications include:

  • "Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer," 2020, New England Journal of Medicine
  • "PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer," 2022, New England Journal of Medicine
  • "Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study," 2022, The Lancet Oncology
  • "Cancer therapy shapes the fitness landscape of clonal hematopoiesis," 2020, Nature Genetics
  • "Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)," 2020, Journal of Clinical Oncology

They frequently collaborate with a range of co-authors, including:

  • Andrea Cercek
  • Michael F. Berger
  • Zsofia K. Stadler
  • Benoît Rousseau
  • Michael B. Foote

Their work has been published across several prominent venues, with notable numbers of publications in:

  • UNC Libraries
  • Journal of Clinical Oncology
  • Annals of Oncology
  • Cancer Research
  • New England Journal of Medicine

Best Publications

  • PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

    Dung T. Le;Jennifer N. Uram;Hao Wang;Bjarne R. Bartlett

  • Cancer Genome Landscapes

    Bert Vogelstein;Nickolas Papadopoulos;Victor E. Velculescu;Shibin Zhou

  • Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

    Dung T. Le;Dung T. Le;Jennifer N. Durham;Jennifer N. Durham;Kellie N. Smith;Hao Wang

  • An Integrated Genomic Analysis of Human Glioblastoma Multiforme

    D. Williams Parsons;Siân Jones;Xiaosong Zhang;Jimmy Cheng-Ho Lin

  • Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    Chetan Bettegowda;Chetan Bettegowda;Mark Sausen;Rebecca J. Leary;Isaac Kinde

  • Circulating Mutant DNA to Assess Tumor Dynamics

    Frank Diehl;Luis Diaz;Kenneth W. Kinzler;Bert Vogelstein

  • Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.

    Aurelien Marabelle;Dung T. Le;Paolo A. Ascierto;Anna Maria Di Giacomo

  • Detection and localization of surgically resectable cancers with a multi-analyte blood test

    Joshua D. Cohen;Lu Li;Yuxuan Wang;Christopher Thoburn

  • Liquid Biopsies: Genotyping Circulating Tumor DNA

    Luis A. Diaz;Alberto Bardelli

  • Fulminant Myocarditis with Combination Immune Checkpoint Blockade

    Douglas B. Johnson;Justin M. Balko;Margaret L. Compton;Spyridon Chalkias

  • Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.

    Thierry André;Kai-Keen Shiu;Tae Won Kim;Benny Vittrup Jensen

  • The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

    Luis A. Diaz;Luis A. Diaz;Richard T. Williams;Jian Wu;Jian Wu;Isaac Kinde

  • Daxx/atrx, men1, and mtor pathway genes are frequently altered in pancreatic neuroendocrine tumors

    Yuchen Jiao;Chanjuan Shi;Barish H. Edil;Roeland F. De Wilde

  • TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

    Patrick J. Killela;Zachary J. Reitman;Yuchen Jiao;Chetan Bettegowda

  • Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

    Siân Jones;Tian Li Wang;Ie Ming Shih;Tsui Lien Mao

  • Detection and quantification of mutations in the plasma of patients with colorectal tumors.

    Frank Diehl;Meng Li;Devin Dressman;Yiping He

  • Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

    Jeanne Tie;Yuxuan Wang;Cristian Tomasetti;Cristian Tomasetti;Lu Li

  • Immunotherapy in colorectal cancer: rationale, challenges and potential.

    Karuna Ganesh;Zsofia K. Stadler;Andrea Cercek;Robin B. Mendelsohn

  • Abstract 5606: Detection of circulating tumor DNA in early and late stage human malignancies

    Chetan Bettegowda;Mark Sausen;Rebecca Leary;Isaac Kinde

  • PD-1 blockade in tumors with mismatch repair deficiency.

    Dung T. Le;Jennifer N. Uram;Hao Wang;Bjarne Bartlett

Frequent Co-Authors

Bert Vogelstein
Bert Vogelstein Johns Hopkins University
Kenneth W. Kinzler
Kenneth W. Kinzler Johns Hopkins University
Zhi Liu
Zhi Liu University of North Carolina at Chapel Hill
Victor E. Velculescu
Victor E. Velculescu Johns Hopkins University School of Medicine
Grant James Anhalt
Grant James Anhalt Johns Hopkins University
Nickolas Papadopoulos
Nickolas Papadopoulos Johns Hopkins University School of Medicine
George J. Giudice
George J. Giudice University of Iowa
Janet A. Fairley
Janet A. Fairley University of Iowa
Ralph H. Hruban
Ralph H. Hruban Johns Hopkins University School of Medicine
David B. Solit
David B. Solit Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine offers various pathways beyond traditional medical school. Many students are considering online schools for health information management to gain expertise in organizing and managing healthcare data—an area with rapid job growth and flexible online options.

For those interested in administrative roles, obtaining certification through medical billing and coding certification cost programs can be an affordable way to enter the healthcare field quickly. These certifications open doors to essential support roles in clinics and hospitals.

Nursing remains a popular medical career, and aspiring nurses now have access to a variety of online nurse practitioner programs and online nursing programs. These programs provide flexible learning options for busy students or working professionals, while maintaining high educational standards.

Online healthcare degrees provide more accessible pathways into medicine and health services, allowing you to start or advance your medical career on your own terms.

Best Scientists Citing Luis A. Diaz

Trending Scientists

Recently Published Articles